ARTG 315113Optipac Refobacin Plus Bone Cement - Orthopaedic cement, medicated
ARTG ID: 315113 · Zimmer Biomet Pty Ltd · Biomet France · Class III · Started March 05, 2019
Good Name: Zimmer Biomet Pty Ltd - Optipac Refobacin Plus Bone Cement - Orthopaedic cement, medicated
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 315113
- Start Date
- March 05, 2019
- Effective Date
- March 05, 2019
- Name
- Biomet France
- Country
- France
- Address
- Plateau de Lautagne, Valence, 26000
Optipac Refobacin Plus Bone Cement is used for stable anchoring of suitable joint prostheses in primary operations, with added protection against infection also in revision operations resulting from aseptic loosening of the prosthesis and infection of the prosthesis by gentamicin-sensitive strains.
Access comprehensive regulatory information for Optipac Refobacin Plus Bone Cement - Orthopaedic cement, medicated in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 315113 and sponsored by Zimmer Biomet Pty Ltd, manufactured by Biomet France in France. The device registration started on March 05, 2019.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.